Trial
NCT05364645
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Lung Non-Small Cell Carcinoma
Intervention
Carboplatin
Why stopped
lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-09